UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D/A
Under the Securities Exchange Act of 1934
(Amendment No. 2 )*
-----
AMEDISYS, INC.
--------------------------------------------------------------------------------
(Name of Issuer)
COMMON
--------------------------------------------------------------------------------
(Title of Class of Securities)
023436108
------------------------------
(CUSIP Number)
David Nierenberg, The D3 Family Fund, 19605 NE 8th St., Camas, WA 98607
(360)604-8600
------------------------------------------------------------------------------
(Name, Address and Telephone Number
of Person Authorized to Receive
Notices and Communications)
10/22/02
-------------------------------
(Date of Event which Requires
Filing of this Statement)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of
that section of the Act but shall be subject to all other provisions of the
Act (however, see the Notes).
1 of 17
SCHEDULE 13D
CUSIP No. 023436108 Page 2 of 17
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
The D3 Family Fund, L.P. (David Nierenberg is President of the General
Partner, which is Nierenberg Investment Management Company, Inc.)
--------------------------------------------------------------------------
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ X ]
(b) [ ]
--------------------------------------------------------------------------
3) SEC USE ONLY
--------------------------------------------------------------------------
4) SOURCE OF FUNDS
WC
--------------------------------------------------------------------------
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
--------------------------------------------------------------------------
6) CITIZENSHIP OR PLACE OF ORGANIZATION
Washington
--------------------------------------------------------------------------
7) SOLE VOTING POWER
NUMBER OF
912,000 (10.1%)
SHARES --------------------------------------------------
BENEFICIALLY 8) SHARED VOTING POWER
OWNED BY 0
--------------------------------------------------
EACH
9) SOLE DISPOSITIVE POWER
REPORTING
912,000
PERSON --------------------------------------------------
WITH 10) SHARED DISPOSITIVE POWER
0
--------------------------------------------------
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
Aggregate amount owned is 979,000 shares (10.8%)
--------------------------------------------------------------------------
12) CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [ ]
--------------------------------------------------------------------------
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.8%
--------------------------------------------------------------------------
14) TYPE OF REPORTING PERSON*
PN
--------------------------------------------------------------------------
SCHEDULE 13D
CUSIP No. 023436108 Page 3 of 17
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Haredale, Ltd.
--------------------------------------------------------------------------
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ X ]
(b) [ ]
--------------------------------------------------------------------------
3) SEC USE ONLY
--------------------------------------------------------------------------
4) SOURCE OF FUNDS
WC
--------------------------------------------------------------------------
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
--------------------------------------------------------------------------
6) CITIZENSHIP OR PLACE OF ORGANIZATION
The Bahamas
--------------------------------------------------------------------------
7) SOLE VOTING POWER
NUMBER OF
24,500 (0.3%)
SHARES --------------------------------------------------
BENEFICIALLY 8) SHARED VOTING POWER
OWNED BY 0
--------------------------------------------------
EACH
9) SOLE DISPOSITIVE POWER
REPORTING
24,500
PERSON --------------------------------------------------
WITH 10) SHARED DISPOSITIVE POWER
0
--------------------------------------------------
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
Aggregate amount owned is 979,000 shares (10.8%)
--------------------------------------------------------------------------
12) CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [ ]
--------------------------------------------------------------------------
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.8%
--------------------------------------------------------------------------
14) TYPE OF REPORTING PERSON*
CO
--------------------------------------------------------------------------
SCHEDULE 13D
CUSIP No. 023436108 Page 4 of 17
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Olivier Roux
--------------------------------------------------------------------------
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ X ]
(b) [ ]
--------------------------------------------------------------------------
3) SEC USE ONLY
--------------------------------------------------------------------------
4) SOURCE OF FUNDS
WC
--------------------------------------------------------------------------
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
--------------------------------------------------------------------------
6) CITIZENSHIP OR PLACE OF ORGANIZATION
French citizen resident in United Kingdom
--------------------------------------------------------------------------
7) SOLE VOTING POWER
NUMBER OF
10,000 (0.1%)
SHARES --------------------------------------------------
BENEFICIALLY 8) SHARED VOTING POWER
OWNED BY 0
--------------------------------------------------
EACH
9) SOLE DISPOSITIVE POWER
REPORTING
10,000
PERSON --------------------------------------------------
WITH 10) SHARED DISPOSITIVE POWER
0
--------------------------------------------------
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
Aggregate amount owned is 979,000 shares (10.8%)
--------------------------------------------------------------------------
12) CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [ ]
--------------------------------------------------------------------------
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.8%
--------------------------------------------------------------------------
14) TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------
SCHEDULE 13D
CUSIP No. 023436108 Page 5 of 17
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
James Henry Hildebrandt
--------------------------------------------------------------------------
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ X ]
(b) [ ]
--------------------------------------------------------------------------
3) SEC USE ONLY
--------------------------------------------------------------------------
4) SOURCE OF FUNDS
WC
--------------------------------------------------------------------------
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
--------------------------------------------------------------------------
6) CITIZENSHIP OR PLACE OF ORGANIZATION
Canadian citizen resident in Hong Kong
--------------------------------------------------------------------------
7) SOLE VOTING POWER
NUMBER OF
7,000 (0.1%)
SHARES --------------------------------------------------
BENEFICIALLY 8) SHARED VOTING POWER
OWNED BY 0
--------------------------------------------------
EACH
9) SOLE DISPOSITIVE POWER
REPORTING
7,000
PERSON --------------------------------------------------
WITH 10) SHARED DISPOSITIVE POWER
0
--------------------------------------------------
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
Aggregate amount owned is 979,000 shares (10.8%)
--------------------------------------------------------------------------
12) CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [ ]
--------------------------------------------------------------------------
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.8%
--------------------------------------------------------------------------
14) TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------
SCHEDULE 13D
CUSIP No. 023436108 Page 6 of 17
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Toxford Corporation
--------------------------------------------------------------------------
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ X ]
(b) [ ]
--------------------------------------------------------------------------
3) SEC USE ONLY
--------------------------------------------------------------------------
4) SOURCE OF FUNDS
WC
--------------------------------------------------------------------------
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
--------------------------------------------------------------------------
6) CITIZENSHIP OR PLACE OF ORGANIZATION
Channel Islands, British Isles
--------------------------------------------------------------------------
7) SOLE VOTING POWER
NUMBER OF
4,000 (0.0%)
SHARES --------------------------------------------------
BENEFICIALLY 8) SHARED VOTING POWER
OWNED BY 0
--------------------------------------------------
EACH
9) SOLE DISPOSITIVE POWER
REPORTING
4,000
PERSON --------------------------------------------------
WITH 10) SHARED DISPOSITIVE POWER
0
--------------------------------------------------
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
Aggregate amount owned is 979,000 shares (10.8%)
--------------------------------------------------------------------------
12) CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [ ]
--------------------------------------------------------------------------
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.8%
--------------------------------------------------------------------------
14) TYPE OF REPORTING PERSON*
CO
--------------------------------------------------------------------------
SCHEDULE 13D
CUSIP No. 023436108 Page 7 of 17
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Henry E. Hooper
--------------------------------------------------------------------------
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ X ]
(b) [ ]
--------------------------------------------------------------------------
3) SEC USE ONLY
--------------------------------------------------------------------------
4) SOURCE OF FUNDS
WC
--------------------------------------------------------------------------
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
--------------------------------------------------------------------------
6) CITIZENSHIP OR PLACE OF ORGANIZATION
Washington
--------------------------------------------------------------------------
7) SOLE VOTING POWER
NUMBER OF
1,500 (0.0%)
SHARES --------------------------------------------------
BENEFICIALLY 8) SHARED VOTING POWER
OWNED BY 0
--------------------------------------------------
EACH
9) SOLE DISPOSITIVE POWER
REPORTING
1,500
PERSON --------------------------------------------------
WITH 10) SHARED DISPOSITIVE POWER
0
--------------------------------------------------
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
Aggregate amount owned is 979,000 shares (10.8%)
--------------------------------------------------------------------------
12) CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [ ]
--------------------------------------------------------------------------
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.8%
--------------------------------------------------------------------------
14) TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------
SCHEDULE 13D
CUSIP No. 023436108 Page 8 of 17
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Florence Cies
--------------------------------------------------------------------------
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ X ]
(b) [ ]
--------------------------------------------------------------------------
3) SEC USE ONLY
--------------------------------------------------------------------------
4) SOURCE OF FUNDS
WC
--------------------------------------------------------------------------
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
--------------------------------------------------------------------------
6) CITIZENSHIP OR PLACE OF ORGANIZATION
California
--------------------------------------------------------------------------
7) SOLE VOTING POWER
NUMBER OF
10,000 (0.1%)
SHARES --------------------------------------------------
BENEFICIALLY 8) SHARED VOTING POWER
OWNED BY 0
--------------------------------------------------
EACH
9) SOLE DISPOSITIVE POWER
REPORTING
10,000
PERSON --------------------------------------------------
WITH 10) SHARED DISPOSITIVE POWER
0
--------------------------------------------------
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
Aggregate amount owned is 979,000 shares (10.8%)
--------------------------------------------------------------------------
12) CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [ ]
--------------------------------------------------------------------------
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.8%
--------------------------------------------------------------------------
14) TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------
SCHEDULE 13D
CUSIP No. 023436108 Page 9 of 17
1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
The David and Patricia Nierenberg 1993 Irrevocable Trust,
Lawrence K. Orr, Trustee, June 11, 1993
--------------------------------------------------------------------------
2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ X ]
(b) [ ]
--------------------------------------------------------------------------
3) SEC USE ONLY
--------------------------------------------------------------------------
4) SOURCE OF FUNDS
WC
--------------------------------------------------------------------------
5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
--------------------------------------------------------------------------
6) CITIZENSHIP OR PLACE OF ORGANIZATION
Washington
--------------------------------------------------------------------------
7) SOLE VOTING POWER
NUMBER OF
10,000 (0.1%)
SHARES --------------------------------------------------
BENEFICIALLY 8) SHARED VOTING POWER
OWNED BY 0
--------------------------------------------------
EACH
9) SOLE DISPOSITIVE POWER
REPORTING
10,000
PERSON --------------------------------------------------
WITH 10) SHARED DISPOSITIVE POWER
0
--------------------------------------------------
11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
Aggregate amount owned is 979,000 shares (10.8%)
--------------------------------------------------------------------------
12) CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [ ]
--------------------------------------------------------------------------
13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.8%
--------------------------------------------------------------------------
14) TYPE OF REPORTING PERSON*
OO (Irrevocable trust)
--------------------------------------------------------------------------
Page 10 of 17
Item 1. Security and Issuer
Common stock of Amedisys, Inc. (AMED),
11100 Mead Road, Suite 300,
Baton Rouge, LA 70816
Item 2. Identity and Background
The D3 Family Fund, L.P., a Washington State limited partnership, whose
principal business is investing in domestic micro-cap public equities.
Located at 19605 N.E. 8th St., Camas, Washington 98607. No convictions
or administrative proceedings as described in Item 2(d) and (e).
Item 3. Source and Amount of Funds or Other Consideration
Source of funds is money invested in the partnership by its partners.
Aggregate amount invested by D3 in AMED is $6,437,700.
Item 4. Purpose of Transaction
We have modified the objective of our investment in Amedisys from
passive investment to a more active role in helping the company build
the capabilities and resources required to exploit fully the market
opportunities available to it. In September, 2002, we wrote to the
board of directors making suggestions about governance, profitability,
and financial public relations. We continue to address these topics
with members of the board, with management, and with other shareholders
of the company. We believe that recent concerns about reimbursement
rates have driven the share price to an extremely undervalued level.
Item 5. Interest in Securities of the Issuer
(a,b) D3 owns and has sole voting power over 820,000 AMED shares.
(c) D3's transactions in the last 60 days:
Date # of shares Price paid
-------- ----------- ----------
10/21/02 79,000 $5.92
10/22 13,000 5.83
(d) N/A
(e) N/A
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer
N/A
Item 7. Material to be Filed as Exhibits
N/A
Signature
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
October 22, 2002 /s/DAVID NIERENBERG
----------------- ------------------------------------
Date David Nierenberg
President
Nierenberg Investment Management
Company, Inc., the General Partner
of The D3 Family Fund, L.P.
Page 11 of 17
Item 1. Security and Issuer
Common stock of Amedisys, Inc. (AMED),
11100 Mead Road, Suite 300,
Baton Rouge, LA 70816
Item 2. Identity and Background
(a) Haredale Ltd., a Bahamian corporation.
(b) P.O. Box N-4465, Nassau, New Providence, The Bahamas.
(c) Haredale is in the investment business at the address above.
(d) None
(e) None
(f) The Bahamas.
Item 3. Source and Amount of Funds or Other Consideration
Haredale owns, and Mr. Nierenberg has sole voting and dispositive
power over, its 24,500 shares.
Item 4. Purpose of Transaction
See Item 4., page 10.
Item 5. Interest in Securities of the Issuer
(a,b) Haredale owns, and Mr. Nierenberg has sole voting and
dispositive power over, its 24,500 shares.
(c) N/A
(d) N/A
(e) N/A
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer
Haredale pays Mr. Nierenberg an annual management fee and a share
of its net profits for his personal management of its account.
Item 7. Material to be Filed as Exhibits
N/A
Signature
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.
October 22, 2002 /s/DAVID NIERENBERG
------------------ ------------------------------------
Date David Nierenberg
Authorized to trade for
Haredale, Ltd.
Page 12 of 17
Item 1. Security and Issuer
Common stock of Amedisys, Inc. (AMED),
11100 Mead Road, Suite 300,
Baton Rouge, LA 70816
Item 2. Identity and Background
(a) Olivier Roux, a French citizen resident in the United Kingdom.
(b) Talisman Management Ltd., 37 Ixworth Place, London SW3, England.
(c) Mr. Roux is a management consultant.
(d) None
(e) None
(f) A French citizen resident in the United Kingdom.
Item 3. Source and Amount of Funds or Other Consideration
Mr. Roux owns, and Mr. Nierenberg has sole voting and dispositive power
over, his 10,000 AMED shares.
Item 4. Purpose of Transaction
See Item 4., page 10.
Item 5. Interest in Securities of the Issuer
(a,b) Mr. Roux owns, and Mr. Nierenberg has sole voting and
dispositive power over, his 10,000 AMED shares.
(c) N/A
(d) N/A
(e) N/A
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer
Mr. Roux pays Mr. Nierenberg an annual management fee and a share of
its net profits for his personal management of Mr. Roux's account.
Item 7. Material to be Filed as Exhibits
N/A
Signature
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
October 22, 2002 /s/DAVID NIERENBERG
------------------ ------------------------------------
Date David Nierenberg
Authorized to trade for
Olivier Roux
Page 13 of 17
Item 1. Security and Issuer
Common stock of Amedisys, Inc. (AMED),
11100 Mead Road, Suite 300,
Baton Rouge, LA 70816
Item 2. Identity and Background
(a) James Henry Hildebrandt a Canadian citizen resident in Hong Kong.
(b) c/o Bain & Company, Tenth Floor, One Pacific Place, 88 Queensway,
Hong Kong.
(c) Mr. Hildebrandt is a management consultant.
(d) None
(e) None
(f) A Canadian citizen resident in Hong Kong.
Item 3. Source and Amount of Funds or Other Consideration
Mr. Hildebrandt owns, and Mr. Nierenberg has sole voting and
dispositive power over, his 7,000 AMED shares.
Item 4. Purpose of Transaction
See Item 4., page 10.
Item 5. Interest in Securities of the Issuer
(a,b) Mr. Hildebrandt owns, and Mr. Nierenberg has sole voting and
dispositive power over, his 7,000 AMED shares.
(c) N/A
(d) N/A
(e) N/A
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer
Mr. Hildebrandt pays Mr. Nierenberg an annual management fee and a
share of its net profits for his personal management of his account.
Item 7. Material to be Filed as Exhibits
N/A
Signature
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
October 22, 2002 /s/DAVID NIERENBERG
------------------ ------------------------------------
Date David Nierenberg
Authorized to trade for
John Henry Hildebrandt
Page 14 of 17
Item 1. Security and Issuer
Common stock of Amedisys, Inc. (AMED),
11100 Mead Road, Suite 300,
Baton Rouge, LA 70816
Item 2. Identity and Background
(a) Toxford Corporation, a Channel Islands corporation.
(b) P.O. Box 3048, St. Andrews House, Le Bordage, St. Peter Port,
Guernsey, Channel Islands, British Isles.
(c) Toxford Corporation is in the investment business.
(d) None
(e) None
(f) Channel Islands, British Isles.
Item 3. Source and Amount of Funds or Other Consideration
Toxford Corporation owns, and Mr. Nierenberg has sole voting and
dispositive power over, its 4,000 AMED shares.
Item 4. Purpose of Transaction
See Item 4., page 10.
Item 5. Interest in Securities of the Issuer
(a,b) Toxford Corporation owns, and Mr. Nierenberg has sole voting and
dispositive power over, its 4,000 AMED shares.
(c) N/A
(d) N/A
(e) N/A
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer
Toxford Corporation pays Mr. Nierenberg an annual management fee and a
share of its net profits for his personal management of its account.
Item 7. Material to be Filed as Exhibits
N/A
Signature
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
October 22, 2002 /s/DAVID NIERENBERG
------------------ ------------------------------------
Date David Nierenberg
Authorized to trade for
Toxford Corporation
Page 15 of 17
Item 1. Security and Issuer
Common stock of Amedisys, Inc. (AMED),
11100 Mead Road, Suite 300,
Baton Rouge, LA 70816
Item 2. Identity and Background
(a) Henry Hooper, a United States Citizen.
(b) 2900 SE 149th Court, Vancouver, WA 98783.
(c) Mr. Hooper is a General Partner of the D3 Family Fund, LP.
(d) No convictions or administrative proceedings as described in Items
2(d) and (e).
(e) None.
(f) United States, resident of Washington State.
Item 3. Source and Amount of Funds or Other Consideration
Mr. Hooper has sole voting and dispositive power over, his 1,500 AMED
shares.
Item 4. Purpose of Transaction
See Item 4., page 10.
Item 5. Interest in Securities of the Issuer
(a,b) Mr. Hooper has sole voting and dispositive power over, his
1,500 AMED shares.
(c) N/A
(d) N/A
(e) N/A
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer
N/A
Item 7. Material to be Filed as Exhibits
N/A
Signature
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
October 22, 2002 /s/DAVID NIERENBERG
----------------- ------------------------------------
Date David Nierenberg
President
Nierenberg Investment Management
Company, Inc., the General Partner
of The D3 Family Fund, L.P.
Page 16 of 17
Item 1. Security and Issuer
Common stock of Amedisys, Inc. (AMED),
11100 Mead Road, Suite 300,
Baton Rouge, LA 70816
Item 2. Identity and Background
(a) Florence Cies, an American Citizen.
(b) 3300 Narvaez, #26, San Jose, California 95136
(c) Cies is retired.
(d) None
(e) None
(f) American
Item 3. Source and Amount of Funds or Other Consideration
Cies owns, and Mr. Nierenberg has sole voting and
dispositive power over, her 10,000 AMED shares.
Item 4. Purpose of Transaction
See Item 4., page 10.
Item 5. Interest in Securities of the Issuer
(a,b) Cies owns, and Mr. Nierenberg has sole voting and
dispositive power over, her 10,000 AMED shares.
(c) Transactions in the last 60 days:
Date # of shares Price paid
-------- ----------- ----------
8/13/02 10,000 $7.20
(d) N/A
(e) N/A
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer
N/A
Item 7. Material to be Filed as Exhibits
N/A
Signature
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
October 22, 2002 /s/DAVID NIERENBERG
------------------ ------------------------------------
Date David Nierenberg
Authorized to trade for
Florence Cies
Page 17 of 17
Item 1. Security and Issuer
Common stock of Amedisys, Inc. (AMED),
11100 Mead Road, Suite 300,
Baton Rouge, LA 70816
Item 2. Identity and Background
(a) The David and Patricia Nierenberg 1993 Irrevocable Trust, Lawrence
K. Orr, Trustee, June 11, 1993
(b) Lawrence K. Orr, Trinity Ventures, 3000 Sand Hill Rd., Bldg. 4,
Suite 160, Menlo Park, CA 94025.
(c) This is an irrevocable trust for the benefit of the Nierenberg
children.
(d) None
(e) None
(f) A California trust.
Item 3. Source and Amount of Funds or Other Consideration
Mr. Orr has sole voting and dispositive power over the trust's 11,000
AMED shares.
Item 4. Purpose of Transaction
See Item 4., page 10.
Item 5. Interest in Securities of the Issuer
(a,b) Mr. Orr has sole voting and dispositive power over the trust's
11,000 AMED shares.
(c) Transactions in the last 60 days:
Date # of shares Price paid
-------- ----------- ----------
8/13/02 10,000 $7.02
(d) N/A
(e) N/A
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer
N/A
Item 7. Material to be Filed as Exhibits
N/A
Signature
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
October 22, 2002 /s/DAVID NIERENBERG
------------------ ------------------------------------
Date David Nierenberg
Authorized to trade for
The Nierenberg Family 1993 Trust